This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
The Challenge of Scaling Cell and Gene Therapy
Erik Vaessen on the costs, complexities, and technologies shaping advanced therapy manufacturing.
